Maze Therapeutics - Entities Affiliated With Third Rock Ventures Beneficially Owned 20.1% of Common Shares Prior to Offering
Maze Therapeutics - 與第三巖風險投資關聯的實體在發行前持有20.1%的普通股。
Maze Therapeutics - Entities Affiliated With Third Rock Ventures Beneficially Owned 20.1% of Common Shares Prior to Offering
Maze Therapeutics - 與第三巖風險投資關聯的實體在發行前持有20.1%的普通股。
使用瀏覽器的分享功能,分享給你的好友吧